Navigation Links
OncoGenex and Isis Announce OGX-011 Data to be Presented at ASCO

Phase I/II study of OGX-011 and a gemcitabine (GEM)/platinum regimen as first-line therapy in 85 patients with advanced non-small cell lung cancer" Abstract Number: 7596 Session: Lung Cancer, Poster Board # P10 Location: S Hall A2 Session Time: 8:00 a.m. - 12:00 p.m. Presenter: Janessa J. Laskin, M.D. About OGX-011

OGX-011 is designed to specifically inhibit the production of the cell-survival protein, clusterin. Clusterin production is associated with treatment resistance in many cancers and in response to various cancer treatments, including hormone ablation therapy, chemotherapy and radiation therapy. Preclinical studies have shown that inhibition of clusterin can disable the tumor cell's adaptive defences, render the tumor cells susceptible to attack with a variety of cancer therapies, including chemotherapy, and facilitate tumor cell death. OncoGenex and Isis are collaborating on development of OGX-011.

About OncoGenex

OncoGenex is committed to the development and commercialization of new cancer therapies that address treatment resistance in cancer patients. OncoGenex currently has three product candidates in development: OGX-011, OGX-427 and OGX-225. These product candidates are designed to selectively inhibit the production of proteins that are associated with treatment resistance and that are over-produced in response to a variety of cancer treatments. OncoGenex' aim in targeting these particular proteins is to disable the tumor cells' adaptive defenses, render the tumor cells susceptible to attack with a variety of cancer therapies including chemotherapy, and facilitate tumor cell death. More information on OncoGenex and the company's pipeline is available at www.oncogenex.com.


'"/>




Page: 1 2 3 4

Related medicine technology :

1. OncoGenex Technologies Announces Phase II Data of OGX-011 in Metastatic Breast Cancer at American Association for Cancer Research 2007 Annual Meeting
2. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
3. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
4. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
7. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
8. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
9. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
10. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
11. Protox Announces Positive Clinical Data from Prostate Cancer Study
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: OncoGenex and Isis Announce OGX Data Presented ASCO
(Date:5/23/2013)... 2013  Hadasit Bio-Holdings Ltd. (TASE: HDST, OTC: ... based on intellectual property developed and owned by ... foremost medical research center, today announced that its ... funding from the Israeli Ministry of Industry and ... support product development and advance clinical trials. Cell ...
(Date:5/23/2013)... -- Every day, their baby stopped breathing, his collapsed bronchus blocking ... April and Bryan Gionfriddo watched helplessly, just praying ... a few doctors said he had a good chance of ... , about her now 20-month-old son, Kaiba. "At that ... take it and run with it." They found ...
(Date:5/23/2013)... May 23, 2013   Direct to implant, ... is an appropriate option for many women with ... reduce their breast cancer risk, or with breast ... process and a second surgery to insert permanent ... same surgery as mastectomy can be a medically ...
Breaking Medicine Technology:Hadasit Bio-Holdings Ltd. Portfolio Company - Cell Cure Neurosciences Ltd. Received Additional Government Support 2Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 2Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 3Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 4Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results 2Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results 3
... The epicenter of the technology world moves to Basking Ridge, ... the Korean Trade-Investment Promotion Agency (KOTRA), kicks off later this ... it brings together companies seeking the most innovative and creative ... October 26th at 8:30AM EDT (US & Canada) at the ...
... ReVision Therapeutics Inc. today announced results from a ... slows lesion growth and preserves visual acuity in patients ... dry age-related macular degeneration ( AMD ). The data ... (RBP) levels of 60 percent to 75 percent was ...
Cached Medicine Technology:Top U.S. and Korean Companies to Converge at 2010 Global Partnering Day 2Phase 2b Data Suggest ReVision's Oral Fenretinide (RT-101) Slows Lesion Growth, Preserves Vision and Reduces Incidence of Neovascularization in Geographic Atrophy Patients 2Phase 2b Data Suggest ReVision's Oral Fenretinide (RT-101) Slows Lesion Growth, Preserves Vision and Reduces Incidence of Neovascularization in Geographic Atrophy Patients 3
(Date:5/25/2013)... (PRWEB) May 25, 2013 While some ... those who have died serving our Country, many others ... prolonged partying and recklessness. The DUI attorneys at MacGregor ... DUI checklist to help keep this weekend’s party-goers out ... System , there were more than 950 fatal alcohol-related ...
(Date:5/25/2013)... May 25, 2013 An experienced Chandler ... in partnership with JD Media Surge, LLC. , ... now available and, depending on the treatment, can be ... routine visit, the best method will be chosen for ... during a visit. A special peroxide-based whitening gel is ...
(Date:5/25/2013)... A disorder of the nerves, Diabetic ... According to neuropathy expert doctor Helen C Lin, on ... the disorder affects almost 50% of all Diabetic patients, ... The high blood sugar levels in the body are ... it usually tend to have abnormally high blood sugar ...
(Date:5/25/2013)... 25 (HealthDay News) -- Animals make great companions for senior ... in the car are far more likely to crash than ... The new study included 2,000 licensed drivers aged 70 ... asked how often they drove with their pet in the ... the crash risk was twice as high as among those ...
(Date:5/25/2013)... TX (PRWEB) May 25, 2013 Studies ... those who are carrying excessive weight and their inability ... for many, simply losing weight can naturally relieve many ... found that improvement in sleep quality was significantly associated ... six month study dated November 6th, 2012, ...
Breaking Medicine News(10 mins):Health News:Criminal Attorneys Provide Memorial Day Weekend DUI Checklist and Safety Information 2Health News:Criminal Attorneys Provide Memorial Day Weekend DUI Checklist and Safety Information 3Health News:Chandler Dentist Launches Teeth Whitening Service Page on Website in Partnership with JD Media Surge, LLC 2Health News:Diabetic Neuropathy treatment hits new grounds- Neuracel launches the complete natural treatment 2Health News:Seniors More Likely to Crash When Driving With Pet: Study 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Offers Newly Improved hCG Diet Plans Capable of Delivering Better Sleep 2
... a method for male contraception that is effective, reversible ... new study accepted for publication in The Endocrine Society,s ... JCEM ). , "For couples who can not, ... have been limited to vasectomy, condom and withdrawal," said ...
... New England States, Enhancement of Health Coverage Programs ... from HealthLeaders-InterStudyNASHVILLE, Tenn., May 4 HealthLeaders-InterStudy, a ... that while Massachusetts, healthcare reform has been successful ... continue the program amid the recession and spiraling ...
... National child advocacy organization grades child health care reform ... days milestone, President Obama continues to enjoy high ratings ... his administration and 111th Congress score an "incomplete" for ... Monday by Voices for America,s Children, a premier national ...
... for organizations in SE Michigan . Event ... professionals. Increase wellness, decrease insurance costs, improve morale, ... 4 Cambridge Employee Benefits, a division of ... corporate Wellness & HR Summit May 21, 2009.The ...
... Prepared with Flu Preparedness Information from American Red CrossCHICAGO, ... are closing down due to the swine flu (H1N1 ... safe and reliable in-home caregiver options. In response ... a 20 percent discount to Sittercity.com for the month ...
... Month draws attention to urgency in preventing stroke and supporting 6 million ... ... -- This year nearly 795,000 people will have a stroke, leaving a ... according to National Stroke Association , which is observing National Stroke ...
Cached Medicine News:Health News:Massachusetts Healthcare Reform Cost Containment Strategy Featured in New Report 2Health News:Kids Group Scores Obama, Congress in 100 Days Report Card 2Health News:Cambridge Employee Benefits to Host Corporate Wellness & HR Summit 2Health News:In-Home Caregivers Standing by Nationwide to Support Increased Need Due to Swine Flu 2Health News:Four of Five Families Will Be Touched by Stroke in 2009 2
... All toggle switches at off (center position) , Double ... by .75 s; repeats every 10 s , Twitch: ... Tetanus: 50 Hz (50 pulses/s) or 100 Hz (100 ... pulses/2 s; repeats every 10 s) , Output Current: ...
... of Operation: , Standby: All toggle switches at ... (1 pulse/s); 10 s (1 pulses/10 s) , ... (100 pulses/s) , Train-Of-Four: Single (4 pulses/2 s); ... , Output Current: Adjustable from 0-70 mA(HI range) ...
... Modes of Operation: , Double Burst : 2 ... , Twitch: 1 s (1 pulse/s) , Tetanus: ... , Train-Of-Four: Single (4 pulses/2 s) , Output ... Square Wave Monophasic pulses (200-us duration) , Indicators: Battery ...
... A standby switch maintains power to the instrument ... (1 pulse/s) , Tetanus: 100 Hz (200 ... Output Current: Adjustable from 0-70 mA , ... , Indicators: Battery LED (green) indicates that the ...
Medicine Products: